Calmare Therapeutics Stock Debt To Equity
| CTTCDelisted Stock | USD 0.0001 0.00 0.00% |
Calmare Therapeutics fundamentals help investors to digest information that contributes to Calmare Therapeutics' financial success or failures. It also enables traders to predict the movement of Calmare Stock. The fundamental analysis module provides a way to measure Calmare Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Calmare Therapeutics stock.
Calmare |
Calmare Therapeutics Company Debt To Equity Analysis
Calmare Therapeutics' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Calmare Therapeutics has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Calmare Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Calmare Therapeutics' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Calmare Therapeutics could also be used in its relative valuation, which is a method of valuing Calmare Therapeutics by comparing valuation metrics of similar companies.Calmare Therapeutics is currently under evaluation in debt to equity category among its peers.
Calmare Fundamentals
| Return On Asset | -0.38 | |||
| Operating Margin | (2.14) % | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 30.38 M | |||
| Shares Owned By Institutions | 6.92 % | |||
| Number Of Shares Shorted | 212.63 K | |||
| Price To Earning | (0.68) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 1.17 M | |||
| Gross Profit | 771.48 K | |||
| EBITDA | (2.43 M) | |||
| Net Income | (3.83 M) | |||
| Cash And Equivalents | 12.55 K | |||
| Current Ratio | 0.22 X | |||
| Book Value Per Share | (0.48) X | |||
| Cash Flow From Operations | (1.24 M) | |||
| Short Ratio | 3.99 X | |||
| Earnings Per Share | (0.13) X | |||
| Target Price | 0.79 | |||
| Beta | 0.57 | |||
| Market Capitalization | 11.09 K | |||
| Total Asset | 3.88 M | |||
| Retained Earnings | (62.01 M) | |||
| Working Capital | (12.68 M) | |||
| Current Asset | 3.96 M | |||
| Current Liabilities | 16.64 M | |||
| Z Score | -24.6 | |||
| Net Asset | 3.88 M |
About Calmare Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calmare Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calmare Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calmare Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |